• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Intertek banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Formulated Solutions to expand its aerosol manufacturing capacity with acquisition of Tennessee facility

Florida-based CDMO Formulated Solutions announced that it has acquired a 455,000 sq ft production facility in Cleveland, TN, USA that includes two buildings fitted with pharmaceutical production and packaging lines for a variety of dose forms such as liquids, bag-on-valve aerosols, and nasal sprays. The Tennessee facility was most recently owned by German skincare company Beiersdorf, which had acquired the plant from Bayer Healthcare in 2019. Formulated Solutions completed an addition of nasal spray manufacturing capabilities to its Florida plant in January 2022.

The company said, “Upon completion, the acquisition will strengthen Formulated Solutions’ capabilities in topicals, metered dose nasal sprays, and pressurized package manufacturing and allow the company to quickly bring additional production capacity online in service of current commercial demand while also paving the way for fulfillment of their future innovation pipeline.”

Formulated Solutions Chief Operating Officer John Maddox commented, “With an average year over year growth of well over 50% annually, Formulated Solutions is thrilled to add the aerosol, bag-on-valve, and liquid-fill capabilities of this 455,000 square foot site to our manufacturing assets. Our customers, consumers, physicians, and patients rely on us each and every day to supply high quality, cost-effective solutions for consumer self-care and physician advised treatments. This acquisition will help us further fulfill that commitment to all our marketing partners as our business continues to grow and evolve.”

Read the Formulated Solutions press release.

Share

published on December 19, 2022

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Merxin We Make Inhalers banner
    © 2025 OINDPnews